These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22151936)

  • 61. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Azelaic Acid Versus Hydroquinone for Managing Patients With Melasma: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Albzea W; AlRashidi R; Alkandari D; Sadan M; Alkandari A; Alkanderi JJ; AlHajri MT; Almutairi SN; Alenzi A; Alanazi S; Al-Qurashi S; Alhajaji R; Al Shami A
    Cureus; 2023 Jul; 15(7):e41796. PubMed ID: 37457606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
    Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
    J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different therapeutic modalities for treatment of melasma.
    Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF
    J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
    Mohamed EM; Younes AH; Hussein GM
    J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
    Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
    Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients.
    Bansal C; Naik H; Kar HK; Chauhan A
    J Cutan Aesthet Surg; 2012 Oct; 5(4):266-72. PubMed ID: 23378709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical 10% zinc sulfate solution for treatment of melasma.
    Sharquie KE; Al-Mashhadani SA; Salman HA
    Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
    Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
    J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety.
    Deo KS; Dash KN; Sharma YK; Virmani NC; Oberai C
    Indian J Dermatol; 2013 Jul; 58(4):281-5. PubMed ID: 23918998
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
    Yasnova N; Sirait SP; Rahmayunita G
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 Jun; 33(2):83-88. PubMed ID: 38918942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
    Chatterjee M; Neema S; Rajput GR
    Indian J Dermatol Venereol Leprol; 2021; 88(1):51-58. PubMed ID: 34379946
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
    Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
    J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas.
    Wattanakrai P; Nimmannitya K
    J Drugs Dermatol; 2022 Dec; 21(12):1304-1310. PubMed ID: 36468967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.
    Fitton A; Goa KL
    Drugs; 1991 May; 41(5):780-98. PubMed ID: 1712709
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
    Del Rosso JQ
    Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.